Humacyte (HUMA)
NASDAQ:HUMA
US Market
Holding HUMA?
Track your performance easily

Humacyte (HUMA) Ownership - Who Owns Humacyte?

898 Followers

Humacyte (HUMA) Ownership Overview

8.49%6.15%0.36%10.83%74.17%
0.36% Other Institutional Investors
10.83% ETFs
74.17% Public Companies and Individual Investors
The ownership structure of Humacyte (HUMA) stock is a mix of institutional, retail, and individual investors. Approximately 17.34% of the company’s stock is owned by Institutional Investors, 8.49% is owned by Insiders, and 74.17% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 11, 2024
xxxxxxxxxxxxx
$28004
Sep 11, 2024
xxxxxxxxxxxxx
$2364521
Sep 11, 2024
Laura E Niklason
Pres, Ceo & Dir,director
xxxxxxxxxxxxx
$2364521
Sep 03, 2024
xxxxxxxxxxxxx
$7992

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$24864
Jun 30, 2024
xxxxxxxxxxxxx
$1549684

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,131,339Insider4.10%27,298,723
5,131,339Insider4.10%27,298,723
4,720,747Institution3.77%25,114,374
4,301,989Institution3.44%22,886,581
3,592,377Institution2.87%19,111,446
2,844,090Institution2.27%15,130,559
1,007,237Institution0.80%5,358,501
971,079Institution0.78%5,166,140
811,358Institution0.65%4,316,425
469,335Institution0.37%2,496,862

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,592,377Institution2.87%19,111,446
1,007,237Institution0.80%5,358,501
971,079Institution0.78%5,166,140
811,358Institution0.65%4,316,425
446,467Institution0.36%2,375,204
278,788Institution0.22%1,483,152
252,783Institution0.20%1,344,806
50,925Institution0.04%270,921
50,642Institution0.04%269,415
36,692Institution0.03%195,201

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,699,406Institution2.16%14,360,840
2,592,815Institution2.07%14,104,914
2,323,763Institution1.86%12,362,419
1,231,925Institution0.98%6,701,672
787,525Institution0.63%4,189,633
659,250Institution0.53%3,507,210
426,892Institution0.34%2,313,755
405,166Institution0.32%2,204,103
277,969Institution0.22%1,512,151
201,035Institution0.16%1,069,506

FAQ

Who Owns Humacyte (HUMA)?
According to the latest TipRanks data, approximately 0.36% of the company's stock is held by institutional investors, 8.49% is held by insiders, and 74.17% is held by retail investors.
    What percentage of Humacyte (HUMA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.36% of Humacyte (HUMA) stock is held by institutional investors.
      What percentage of Humacyte (HUMA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 74.17% of Humacyte (HUMA) stock is held by retail investors.
        Who owns the most shares of Humacyte (HUMA)?
        Brady W Dougan owns the most shares of Humacyte (HUMA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis